Morepen Labs.

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "33.82",
    "chg": -2.31,
    "chgp": "-6.39%",
    "dir": -1,
    "prev_price": "36.13",
    "mcapval": "1,980.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083A01026",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "44.19 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Morepen Laboratories Ltd Falls to 52-Week Low of Rs 33.44 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-falls-to-52-week-low-amid-continued-downtrend-3925890",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_priceRelatedfactors_3925890.png",
        "date": "2026-03-30 16:02:59",
        "description": "For the second consecutive session, Morepen Laboratories Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 33.44 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper, reflecting company-specific concerns."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-sell-3917778",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_mojoScore_3917778.png",
        "date": "2026-03-26 10:10:36",
        "description": "Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-technical-momentum-shifts-amid-bearish-signals-3895656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_technicaldot_3895656.png",
        "date": "2026-03-17 08:02:00",
        "description": "Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum indicators and moving averages signal downward pressure on the stock price."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-sell-3892116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_mojoScore_3892116.png",
        "date": "2026-03-15 10:10:23",
        "description": "Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date perspective on the company's performance and outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Valuation Shifts to Fair Amid Sector Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-valuation-shifts-to-fair-amid-sector-volatility-3878772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_valuationdot_3878772.png",
        "date": "2026-03-09 08:00:30",
        "description": "Morepen Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a potential recalibration of investor sentiment in the Pharmaceuticals & Biotechnology sector. Despite recent price declines, the stock’s valuation metrics now present a more attractive entry point relative to its historical averages and peer group."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-sell-3868901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_mojoScore_3868901.png",
        "date": "2026-03-04 10:10:34",
        "description": "Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-opens-with-significant-gap-down-amid-market-concerns-3863797",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_gapdown_3863797.png",
        "date": "2026-03-02 09:32:40",
        "description": "Morepen Laboratories Ltd experienced a sharp gap down at market open today, reflecting heightened market concerns and a volatile trading session. The stock opened 8.61% lower, continuing a recent downward trend amid mixed technical signals and sector pressures."
      },
      {
        "title": "Morepen Laboratories Gains 11.37%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-gains-1137-5-key-factors-driving-the-weeks-momentum-3862589",
        "imagepath": "",
        "date": "2026-02-28 16:03:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Intraday high surge of 15.55% with exceptional volume</p>\n                    <p><strong>23 Feb:</strong> Strong gap-up opening signalling positive market sentiment</p>\n                    <p><strong>24 Feb:</strong> Exceptional volume surge amid continued price gains</p>\n                    <p><strong>24 Feb:</strong> Valuation shifts from fair to expensive on rising multiples</p>\n                    <p><strong>26 Feb:</strong> Modest price recovery after a dip on 25 Feb</p>\n                    <p><strong>27 Feb:</strong> Week closes at Rs.43.78, outperforming Sensex by 12.33%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                   ..."
      },
      {
        "title": "Morepen Laboratories Sees Exceptional Volume Surge Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-sees-exceptional-volume-surge-amid-strong-price-gains-3852751",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_most_active_equities_by_volume_3852751.png",
        "date": "2026-02-24 10:00:14",
        "description": "Morepen Laboratories Ltd (MOREPENLAB), a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading volume, signalling heightened investor interest and a potential shift in market sentiment. The stock outperformed its sector and broader indices, driven by strong accumulation signals and sustained price gains over recent sessions."
      }
    ],
    "total": 391,
    "sid": "546345",
    "stock_news_url": "https://www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Closure of Trading Window for DP and their immediate relatives for the quarter ended 31 March 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure Of Credit Facility - Kotak Mahindra Bank",
      "datetime": "11-Mar-2026",
      "details": "Please find attached the file",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "10-Mar-2026",
      "details": "Execution of loan agreement and other related documents with KEB Hana Bank",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Morepen Laboratories Ltd Falls to 52-Week Low of Rs 33.44 as Sell-Off Deepens

2026-03-30 16:02:59

For the second consecutive session, Morepen Laboratories Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 33.44 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper, reflecting company-specific concerns.

Read full news article

Morepen Laboratories Ltd is Rated Sell

2026-03-26 10:10:36

Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Morepen Laboratories Ltd Technical Momentum Shifts Amid Bearish Signals

2026-03-17 08:02:00

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum indicators and moving averages signal downward pressure on the stock price.

Read full news article

Morepen Laboratories Ltd is Rated Sell

2026-03-15 10:10:23

Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date perspective on the company's performance and outlook.

Read full news article

Morepen Laboratories Ltd Valuation Shifts to Fair Amid Sector Volatility

2026-03-09 08:00:30

Morepen Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a potential recalibration of investor sentiment in the Pharmaceuticals & Biotechnology sector. Despite recent price declines, the stock’s valuation metrics now present a more attractive entry point relative to its historical averages and peer group.

Read full news article

Morepen Laboratories Ltd is Rated Sell

2026-03-04 10:10:34

Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Morepen Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns

2026-03-02 09:32:40

Morepen Laboratories Ltd experienced a sharp gap down at market open today, reflecting heightened market concerns and a volatile trading session. The stock opened 8.61% lower, continuing a recent downward trend amid mixed technical signals and sector pressures.

Read full news article

Morepen Laboratories Gains 11.37%: 5 Key Factors Driving the Week’s Momentum

2026-02-28 16:03:31

Key Events This Week

23 Feb: Intraday high surge of 15.55% with exceptional volume

23 Feb: Strong gap-up opening signalling positive market sentiment

24 Feb: Exceptional volume surge amid continued price gains

24 Feb: Valuation shifts from fair to expensive on rising multiples

26 Feb: Modest price recovery after a dip on 25 Feb

27 Feb: Week closes at Rs.43.78, outperforming Sensex by 12.33%

...

Read full news article

Morepen Laboratories Sees Exceptional Volume Surge Amid Strong Price Gains

2026-02-24 10:00:14

Morepen Laboratories Ltd (MOREPENLAB), a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading volume, signalling heightened investor interest and a potential shift in market sentiment. The stock outperformed its sector and broader indices, driven by strong accumulation signals and sustained price gains over recent sessions.

Read full news article

View All News